State Ledger
Company profile

Indivior Pharmaceuticals, Inc. CIK 1625297

Ticker
INDV (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
North Chesterfield, VA 23235
Fiscal year end
2025 (FY)
Market Data
Close
$36.04
Change
+$0.21
Change %
0.59%
Volume
107,559

INDV · trading date Oct 12, 2026 · previous close $35.83 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$1.24B
Net income
$210.00M
Total assets
$1.20B
Total liabilities
$1.30B
Stockholders' equity
-$98.00M
Cash & equivalents
$195.00M
Operating income
$262.00M
Operating cash flow
-$27.00M
Capital expenditures
$66.00M

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
21.1%
Net margin
16.9%
Free cash flow
-$93.00M
Free cash flow margin
-7.5%
Liabilities / assets
108.2%
Equity / assets
-8.2%
CapEx / revenue
5.3%
Operating cash flow / net income
-0.13×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $1.24B $210.00M $1.20B $1.30B -$98.00M
2024 $1.19B $7.00M $1.32B $1.65B -$337.00M
2023 $1.09B -$126.00M $1.76B $1.94B -$184.00M
2022 $901.00M -$44.00M — — -$15.00M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 425
2026-09-17
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
North Chesterfield, VA 23235
10710 MIDLOTHIAN TURNPIKE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:00 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Virginia — Public Companies